LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 143

Search options

  1. Article ; Online: A Positron Emission Tomography Ligand for Mutant Huntingtin Sheds Light on Disease.

    Lieberman, Andrew P / Albin, Roger L

    Movement disorders : official journal of the Movement Disorder Society

    2022  Volume 37, Issue 5, Page(s) 893

    MeSH term(s) Humans ; Huntingtin Protein/genetics ; Huntington Disease ; Ligands ; Mutation/genetics ; Positron-Emission Tomography/methods
    Chemical Substances Huntingtin Protein ; Ligands
    Language English
    Publishing date 2022-04-09
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 607633-6
    ISSN 1531-8257 ; 0885-3185
    ISSN (online) 1531-8257
    ISSN 0885-3185
    DOI 10.1002/mds.29019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Spinal and bulbar muscular atrophy.

    Lieberman, Andrew P

    Handbook of clinical neurology

    2018  Volume 148, Page(s) 625–632

    Abstract: Spinal and bulbar muscular atrophy (SBMA) is an adult-onset degenerative disorder of the neuromuscular system resulting in slowly progressive weakness and atrophy of the proximal limb and bulbar muscles. The disease is caused by the expansion of a CAG/ ... ...

    Abstract Spinal and bulbar muscular atrophy (SBMA) is an adult-onset degenerative disorder of the neuromuscular system resulting in slowly progressive weakness and atrophy of the proximal limb and bulbar muscles. The disease is caused by the expansion of a CAG/glutamine tract in the amino-terminus of the androgen receptor. That SBMA exclusively affects males reflects the fact that critical pathogenic events are hormone-dependent. These include translocation of the polyglutamine androgen receptor from the cytoplasm to the nucleus and unfolding of the mutant protein. Studies of the pathology of SBMA subjects have revealed nuclear aggregates of the mutant androgen receptor, loss of lower motor neurons in the brainstem and spinal cord, and both neurogenic and myopathic changes in skeletal muscle. Mechanisms underlying disease pathogenesis include toxicity in both lower motor neurons and skeletal muscle, where effects on transcription, intracellular transport, and mitochondrial function have been documented. Therapies to treat SBMA patients remain largely supportive, although experimental approaches targeting androgen action or promoting degradation of the mutant androgen receptor protein or the encoding RNA are under active study.
    MeSH term(s) Animals ; Brain Stem/pathology ; Disease Models, Animal ; Humans ; Motor Neurons/pathology ; Muscular Atrophy, Spinal/genetics ; Muscular Atrophy, Spinal/pathology ; Peptides/genetics ; Receptors, Androgen/genetics ; Spinal Cord/pathology
    Chemical Substances Peptides ; Receptors, Androgen ; polyglutamine (26700-71-0)
    Language English
    Publishing date 2018
    Publishing country Netherlands
    Document type Journal Article ; Review
    ISSN 0072-9752
    ISSN 0072-9752
    DOI 10.1016/B978-0-444-64076-5.00040-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Neuromuscular junction pathology is correlated with differential motor unit vulnerability in spinal and bulbar muscular atrophy.

    Molotsky, Elana / Liu, Yuhong / Lieberman, Andrew P / Merry, Diane E

    Acta neuropathologica communications

    2022  Volume 10, Issue 1, Page(s) 97

    Abstract: Spinal and bulbar muscular atrophy (SBMA) is an X-linked, neuromuscular neurodegenerative disease for which there is no cure. The disease is characterized by a selective decrease in fast-muscle power (e.g., tongue pressure, grip strength) accompanied by ... ...

    Abstract Spinal and bulbar muscular atrophy (SBMA) is an X-linked, neuromuscular neurodegenerative disease for which there is no cure. The disease is characterized by a selective decrease in fast-muscle power (e.g., tongue pressure, grip strength) accompanied by a selective loss of fast-twitch muscle fibers. However, the relationship between neuromuscular junction (NMJ) pathology and fast-twitch motor unit vulnerability has yet to be explored. In this study, we used a cross-model comparison of two mouse models of SBMA to evaluate neuromuscular junction pathology, glycolytic-to-oxidative fiber-type switching, and cytoskeletal alterations in pre- and postsynaptic termini of tibialis anterior (TA), gastrocnemius, and soleus hindlimb muscles. We observed significantly increased NMJ and myofiber pathology in fast-twitch, glycolytic motor units of the TA and gastrocnemius compared to slow-twitch, oxidative motor units of the soleus, as seen by decreased pre- and post-synaptic membrane area, decreased pre- and post-synaptic membrane colocalization, increased acetylcholine receptor compactness, a decrease in endplate area and complexity, and deficits in neurofilament heavy chain. Our data also show evidence for metabolic dysregulation and myofiber atrophy that correlate with severity of NMJ pathology. We propose a model in which the dynamic communicative relationship between the motor neuron and muscle, along with the developmental subtype of the muscle, promotes motor unit subtype specific vulnerability, metabolic alterations, and NMJ pathology.
    MeSH term(s) Animals ; Bulbo-Spinal Atrophy, X-Linked/metabolism ; Bulbo-Spinal Atrophy, X-Linked/pathology ; Mice ; Muscle, Skeletal/pathology ; Muscular Atrophy/metabolism ; Neurodegenerative Diseases/pathology ; Neuromuscular Junction/metabolism ; Pressure ; Tongue/metabolism
    Language English
    Publishing date 2022-07-05
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2715589-4
    ISSN 2051-5960 ; 2051-5960
    ISSN (online) 2051-5960
    ISSN 2051-5960
    DOI 10.1186/s40478-022-01402-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.

    Marchioretti, Caterina / Andreotti, Roberta / Zuccaro, Emanuela / Lieberman, Andrew P / Basso, Manuela / Pennuto, Maria

    Current opinion in pharmacology

    2023  Volume 71, Page(s) 102394

    Abstract: The clinical characteristics of SBMA, also known as Kennedy's disease (OMIM 313200), were initially documented by Dr. H Kawahara in the 18th century and a hundred years later by Dr. W. Kennedy. SBMA is a neuromuscular disease caused by expansions of a ... ...

    Abstract The clinical characteristics of SBMA, also known as Kennedy's disease (OMIM 313200), were initially documented by Dr. H Kawahara in the 18th century and a hundred years later by Dr. W. Kennedy. SBMA is a neuromuscular disease caused by expansions of a CAG microsatellite tandem repeat in exon 1 of the androgen receptor (AR) gene located on the X chromosome. These expansions result in the production of AR with an aberrantly expanded polyglutamine (polyQ) tract. In this review, we explore recent advancements in the significance of gene expression changes in skeletal muscle and discuss how pharmacological interventions targeting this aspect of disease pathogenesis can potentially be translated into therapies for SBMA patients.
    MeSH term(s) Humans ; Bulbo-Spinal Atrophy, X-Linked/drug therapy ; Bulbo-Spinal Atrophy, X-Linked/genetics ; Bulbo-Spinal Atrophy, X-Linked/metabolism ; Receptors, Androgen/genetics ; Receptors, Androgen/metabolism ; Receptors, Androgen/therapeutic use ; Muscle, Skeletal/metabolism ; Muscular Atrophy
    Chemical Substances Receptors, Androgen
    Language English
    Publishing date 2023-07-16
    Publishing country England
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2037057-X
    ISSN 1471-4973 ; 1471-4892
    ISSN (online) 1471-4973
    ISSN 1471-4892
    DOI 10.1016/j.coph.2023.102394
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: High Cholesterol at the Heart of Phagolysosomal Damage.

    Lieberman, Andrew P / Swanson, Joel A

    Cell metabolism

    2018  Volume 27, Issue 3, Page(s) 487–488

    Abstract: Phagolysosome membrane rupture can trigger a maladaptive immune response that promotes tissue damage. In Science, Cantuti-Castelvetri et al. (2018) report that cholesterol-rich myelin debris overwhelms reverse cholesterol transport in aged phagocytes, ... ...

    Abstract Phagolysosome membrane rupture can trigger a maladaptive immune response that promotes tissue damage. In Science, Cantuti-Castelvetri et al. (2018) report that cholesterol-rich myelin debris overwhelms reverse cholesterol transport in aged phagocytes, leading to cholesterol crystal formation, damaged phagolysosomes, and limited tissue repair.
    MeSH term(s) Central Nervous System ; Cholesterol ; Myelin Sheath ; Phagosomes ; Remyelination
    Chemical Substances Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2018-03-20
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2176834-1
    ISSN 1932-7420 ; 1550-4131
    ISSN (online) 1932-7420
    ISSN 1550-4131
    DOI 10.1016/j.cmet.2018.02.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The intersection of lysosomal and endoplasmic reticulum calcium with autophagy defects in lysosomal diseases.

    Liu, Elaine A / Lieberman, Andrew P

    Neuroscience letters

    2018  Volume 697, Page(s) 10–16

    Abstract: The lysosomal storage disorders (LSDs) encompass a group of more than 50 inherited diseases characterized by the accumulation of lysosomal substrates. Two-thirds of patients experience significant neurological symptoms, but the mechanisms of ... ...

    Abstract The lysosomal storage disorders (LSDs) encompass a group of more than 50 inherited diseases characterized by the accumulation of lysosomal substrates. Two-thirds of patients experience significant neurological symptoms, but the mechanisms of neurodegeneration are not well understood. Interestingly, a wide range of LSDs show defects in both autophagy and Ca
    MeSH term(s) Animals ; Autophagy/physiology ; Biological Transport ; Calcium/metabolism ; Endoplasmic Reticulum/metabolism ; Homeostasis ; Humans ; Lysosomal Storage Diseases/metabolism ; Lysosomal Storage Diseases/pathology ; Lysosomes/metabolism
    Chemical Substances Calcium (SY7Q814VUP)
    Language English
    Publishing date 2018-04-25
    Publishing country Ireland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 194929-9
    ISSN 1872-7972 ; 0304-3940
    ISSN (online) 1872-7972
    ISSN 0304-3940
    DOI 10.1016/j.neulet.2018.04.049
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Truth and transparency in a time of crisis.

    Collins, Kathleen L / Markel, Howard / Lieberman, Andrew P

    JCI insight

    2020  Volume 5, Issue 6

    Abstract: Lessons from history underline the importance of having direct lines of communication to and from public health officials, who must remain free from policital bias in times of crisis. ...

    Abstract Lessons from history underline the importance of having direct lines of communication to and from public health officials, who must remain free from policital bias in times of crisis.
    MeSH term(s) COVID-19 ; History, 20th Century ; Humans ; Influenza Pandemic, 1918-1919/history ; Public Health/history ; SARS-CoV-2 ; Truth Disclosure
    Language English
    Publishing date 2020-03-17
    Publishing country United States
    Document type Editorial ; Historical Article
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.138132
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: TDP-43 proteinopathy occurs independently of autophagic substrate accumulation and underlies nuclear defects in Niemann-Pick C disease.

    Liu, Elaine A / Mori, Erika / Hamasaki, Fuko / Lieberman, Andrew P

    Neuropathology and applied neurobiology

    2021  Volume 47, Issue 7, Page(s) 1019–1032

    Abstract: Aims: Neuronal cytoplasmic inclusions of TAR-DNA binding protein of 43 kDa (TDP-43) are a pathological hallmark of diverse neurodegenerative disorders, yet the processes that mediate their formation and their functional significance remain incompletely ... ...

    Abstract Aims: Neuronal cytoplasmic inclusions of TAR-DNA binding protein of 43 kDa (TDP-43) are a pathological hallmark of diverse neurodegenerative disorders, yet the processes that mediate their formation and their functional significance remain incompletely understood. Both dysfunction in autophagy and neuroinflammation have been linked to TDP-43 mislocalisation. Here, we investigate TDP-43 proteinopathy in Niemann-Pick type C disease (NPC), an autosomal recessive lysosomal storage disease (LSD) distinguished by the accumulation of unesterified cholesterol within late endosomes and lysosomes. NPC is characterised by neurodegeneration, neuroinflammation and multifocal disruption of the autophagy pathway.
    Methods: We utilised immunohistochemistry, confocal microscopy, electron microscopy and biochemical and gene expression studies to characterise TDP-43 pathology and autophagic substrate accumulation in Npc1-deficient mice.
    Results: In the NPC brain, cytoplasmic TDP-43 mislocalisation was independent of autophagic substrate accumulation. These pathologies occurred in distinct neuronal subtypes, as brainstem cholinergic neurons were more susceptible to TDP-43 mislocalisation, whereas glutamatergic neurons exhibited hallmarks of autophagic dysfunction. Furthermore, TDP-43 mislocalisation did not co-localise with markers of stress granules or progress to ubiquitinated aggregates over months in vivo, indicating a stable, early stage in the aggregation process. Neither microgliosis nor neuroinflammation were sufficient to drive TDP-43 proteinopathy in the NPC brain. Notably, cytoplasmic TDP-43 co-localised with the nuclear import factor importin α, and TDP-43 mislocalised neurons demonstrated nuclear membrane abnormalities and disruption of nucleocytoplasmic transport.
    Conclusion: Our findings highlight the relationship between LSDs and TDP-43 proteinopathy, define its functional importance in NPC by triggering nuclear dysfunction, and expand the spectrum of TDP-43 pathology in the diseased brain.
    MeSH term(s) Animals ; Autophagy/genetics ; Brain/pathology ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Intracellular Signaling Peptides and Proteins/metabolism ; Lysosomes/metabolism ; Mice ; Neuroinflammatory Diseases/genetics ; Neuroinflammatory Diseases/metabolism ; Neuroinflammatory Diseases/pathology ; Neurons/pathology ; Niemann-Pick Disease, Type C/genetics ; Niemann-Pick Disease, Type C/metabolism ; Niemann-Pick Disease, Type C/pathology ; TDP-43 Proteinopathies/genetics ; TDP-43 Proteinopathies/metabolism
    Chemical Substances DNA-Binding Proteins ; Intracellular Signaling Peptides and Proteins ; TDP-43 protein, mouse
    Language English
    Publishing date 2021-06-15
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80371-6
    ISSN 1365-2990 ; 0305-1846
    ISSN (online) 1365-2990
    ISSN 0305-1846
    DOI 10.1111/nan.12738
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: The Ubiquitination, Disaggregation and Proteasomal Degradation Machineries in Polyglutamine Disease.

    Nath, Samir R / Lieberman, Andrew P

    Frontiers in molecular neuroscience

    2017  Volume 10, Page(s) 78

    Abstract: Polyglutamine disorders are chronic, progressive neurodegenerative diseases caused by expansion of a glutamine tract in widely expressed genes. Despite excellent models of disease, a well-documented clinical history and progression, and established ... ...

    Abstract Polyglutamine disorders are chronic, progressive neurodegenerative diseases caused by expansion of a glutamine tract in widely expressed genes. Despite excellent models of disease, a well-documented clinical history and progression, and established genetic causes, there are no FDA approved, disease modifying treatments for these disorders. Downstream of the mutant protein, several divergent pathways of toxicity have been identified over the last several decades, supporting the idea that targeting only one of these pathways of toxicity is unlikely to robustly alleviate disease progression. As a result, a vast body of research has focused on eliminating the mutant protein to broadly prevent downstream toxicity, either by silencing mutant protein expression or leveraging the endogenous protein quality control machinery. In the latter approach, a focus has been placed on four critical components of mutant protein degradation that are active in the nucleus, a key site of toxicity: disaggregation, ubiquitination, deubiquitination, and proteasomal activity. These machineries have unique functional components, but work together as a cellular defense system that can be successfully leveraged to alleviate disease phenotypes in several models of polyglutamine toxicity. This review will highlight recent advances in understanding both the potential and role of these components of the protein quality control machinery in polyglutamine disease pathophysiology.
    Language English
    Publishing date 2017-03-22
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2452967-9
    ISSN 1662-5099
    ISSN 1662-5099
    DOI 10.3389/fnmol.2017.00078
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The cholesterol transporter NPC1 is essential for epigenetic regulation and maturation of oligodendrocyte lineage cells.

    Kunkel, Thaddeus J / Townsend, Alice / Sullivan, Kyle A / Merlet, Jean / Schuchman, Edward H / Jacobson, Daniel A / Lieberman, Andrew P

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 3964

    Abstract: The intracellular cholesterol transporter NPC1 functions in late endosomes and lysosomes to efflux unesterified cholesterol, and its deficiency causes Niemann-Pick disease Type C, an autosomal recessive lysosomal disorder characterized by progressive ... ...

    Abstract The intracellular cholesterol transporter NPC1 functions in late endosomes and lysosomes to efflux unesterified cholesterol, and its deficiency causes Niemann-Pick disease Type C, an autosomal recessive lysosomal disorder characterized by progressive neurodegeneration and early death. Here, we use single-nucleus RNA-seq on the forebrain of Npc1
    MeSH term(s) Animals ; Mice ; Cell Lineage ; Cholesterol/metabolism ; Epigenesis, Genetic ; Membrane Transport Proteins/metabolism ; Niemann-Pick Disease, Type C/genetics ; Niemann-Pick Disease, Type C/metabolism ; Oligodendroglia/metabolism
    Chemical Substances Cholesterol (97C5T2UQ7J) ; Membrane Transport Proteins ; Npc1 protein, mouse
    Language English
    Publishing date 2023-07-05
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-39733-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top